0001104659-22-005429.txt : 20220119 0001104659-22-005429.hdr.sgml : 20220119 20220119160533 ACCESSION NUMBER: 0001104659-22-005429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220118 FILED AS OF DATE: 20220119 DATE AS OF CHANGE: 20220119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gutch Michael CENTRAL INDEX KEY: 0001687333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38670 FILM NUMBER: 22538773 MAIL ADDRESS: STREET 1: C/O ALBIREO PHARMA, INC. STREET 2: 50 MILK STREET, 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc. CENTRAL INDEX KEY: 0001724344 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824592913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 810-0120 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Entasis Therapeutics Ltd DATE OF NAME CHANGE: 20171204 4 1 tm223320-11_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-18 0 0001724344 Entasis Therapeutics Holdings Inc. ETTX 0001687333 Gutch Michael C/O ENTASIS THERAPEUTICS HOLDINGS INC., 35 GATEHOUSE DRIVE WALTHAM MA 02451 0 1 0 0 See Remarks Common Stock 2022-01-18 4 A 0 125000 0 A 167572 D This award vests over four years with twenty-five percent of the award vesting on each anniversary of the date of grant, subject to the reporting person's continued employment with the Company. Chief Financial Officer and Chief Business Officer Michael Gutch 2022-01-19